Following the sale of Rigontec, and two other deals in the biotech space in the DACH region announced this week, Gareth Morgan delves into unquote" data to take a look at the sector.
Deal ends a five-year stint under Foresight ownership, which first invested in 2013
Trevi appointed a chief restructuring officer in 2017 to negotiate a debt restructuring plan
AI business will look to expand beyond marketing and into robotics, healthcare and education
Company's founders and CEO Klaus Schmidt have retained a significant minority stake